Kliniska studier för Psoriasis i Michigan
4 studier för Psoriasis söker deltagare vid platser i Michigan.
Officiell studietext (engelska)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, West Bloomfield
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07013201A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- David Fivenson, MD, PLC, Ann Arbor
- The Derm Institute of West Michigan, Caledonia
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- C.S. Mott Clinical Research Center (CRC), Detroit
- Henry Ford Medical Center, Detroit
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50757, Auburn Hills
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 27 aug. 2026 · NCT07219420Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.